Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.400
-0.060 (-1.73%)
Apr 28, 2026, 3:54 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 93.27 million as of April 28, 2026. Its market cap has decreased by -12.63% in one year.
Market Cap
93.27M
Enterprise Value
145.94M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.40
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 93.27M, a decrease of -86.04%. That is a compound annual growth rate of -31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 93.27M | 5.49% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EXACT Therapeutics AS | 90.47M |
| Aqua Bio Technology ASA | 83.49M |
| Oncoinvent ASA | 221.23M |
| SoftOx Solutions AS | 264.51M |
| Zelluna ASA | 619.97M |
| Lytix Biopharma ASA | 792.07M |
| ArcticZymes Technologies ASA | 1.02B |
| Nykode Therapeutics AS | 1.02B |